spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Clinical Trial Supply Nordics 2018

19-20 June 2018
Copenhagen, Denmark

Building on last year’s success, our CTS team have conducted extensive research to ensure the 2018 event programme covers all the essentials in clinical supply. In the current climate, every pharma and biotech company are trying to reduce unwanted costs, and enhance operational efficiency. To avoid costly setbacks, an innovative and effective strategy needs to be implemented!

Tailored to the Nordics region, the 5th annual conference will include highly relevant case studies, interactive roundtables and panel discussions, to assist you in your next strategic move. Find out what we have in store for you below:  

2018 Agenda Highlights

  • Collaborating with CMOs to Ensure your Drug Reaches its Destination with No Excursions
  • Streamlining your Process Development in Early Phase Trials to Optimize Supplies Quality
  • Exploring Global Regulations to Fulfil any Potential Different Requirement in All Foreign Sites
  • Pinpointing the Pros and Cons of Just In Time Planning for International Supply 

2018 Key Speakers:

  • Francisco Rizzuto, Cargo Specialist Manager for Europe, IATA
  • Jonas Fransson, Director Drug Product Development, SOBI
  • Matti Lahde, Vice President, Production, FIT Biotech
  • Kjell-Are Furnes, CEO, Ably Medical

For more information on this year’s conference, please visit: http://www.arena-international.com/ctsnoridcsor email us at: events@arena-international.com

 
Print this page
Send to a friend
   
spacer
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

White Papers

Bio/Pharmaceutical Methods: Do your Analytical Methods Hold Up to Regulatory Scrutiny?

Eurofins BioPharma Product Testing

As FDA guidelines evolve and drug products on the market begin to age, bio/pharmaceutical manufacturers face scrutiny of the original methods used to support these products. Therefore, manufacturers must re-evaluate these methods to ensure they comply with current FDA expectations. Some manufacturers are even facing consent decrees imposed by the agency requiring them to bring methods up to current standards within a specified timeframe. This exercise requires significant amounts of time and resources, which many manufacturers do not have since they are focused on getting their next products to market. For that reason, some clients have been turning to Eurofins Lancaster Laboratories for support.
More info >>


News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement